Frederick C. Ames - Concepedia

Author

Frederick C. Ames

The University of Texas MD Anderson Cancer Center

Also Known As

F AMES, F C Ames, F. Ames, F. C. Ames, F.C. Ames, FREDERICK C. AMES, Frederick Ames, Frederick C Ames, Frederick C. Ames

148

Publications

11.5K

Citations

H-Index

101

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Society of Surgical Oncology Breast Cancer Care Anderson Hospital

About

Frederick C. Ames is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	67	6.4K
2	Health Sciences	16	17	1.3K
3	Nursing	6	6	355
4	Engineering	1	1	41
5	Public Health	1	1	47

Frederick C. Ames

102

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Local Recurrence Risk after Skin-Sparing and Conventional Mastectomy: A 6-Year Follow-Up Stephen S. Kroll, Andrew Khoo, Eva S. Singletary, Plastic & Reconstructive Surgery Surgical OncologyBreast OncologySurgeryDermatologyOncology	1999	343
Pathological assessment of response to induction chemotherapy in breast cancer. Lorne D. Feldman, Gabriel N. Hortobágyi, Aman U. Buzdar, PubMed Tumor BiologySurgical OncologyOncologyBreast OncologySurgical Pathology	1986	341
Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer Rosa F. Hwang, Savitri Krishnamurthy, Kelly K. Hunt, Annals of Surgical Oncology Breast OncologyNonsentinel Axillary NodesMedicinePathologyClinicopathologic Factors	2003	284
Effect of Primary Tumor Extirpation in Breast Cancer Patients Who Present With Stage IV Disease and an Intact Primary Tumor Gildy V. Babiera, Roshni Rao, Lei Feng, Annals of Surgical Oncology Surgical OncologyBreast OncologyBreast Cancer PatientsIntact Primary TumorMedicine	2006	282
Sentinel Lymph Node Biopsy Is Accurate After Neoadjuvant Chemotherapy for Breast Cancer Tara M. Breslin, Lisa F. Cohen, Ayşegül A. Şahin, Journal of Clinical Oncology	2000	274
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center Naoto T. Ueno, Aman U. Buzdar, S. Eva Singletary, Cancer Chemotherapy and Pharmacology Surgical OncologyOncologyBreast OncologyCancer ManagementBreast Cancer	1997	257
Classifying local disease recurrences after breast conservation therapy based on location and histology Eugene Huang, Thomas A. Buchholz, Funda Meric, Cancer	2002	253
Role for Intraoperative Margin Assessment in Patients Undergoing Breast-Conserving Surgery Neslihan Cabıoğlu, Kelly K. Hunt, Ayşegül A. Şahin, Annals of Surgical Oncology Intraoperative ConsultationGynecologic SurgeryPatient SafetyPostoperative ConsiderationOutcomes Research	2007	251
Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer Aman U. Buzdar, S. Eva Singletary, Richard L. Theriault, Journal of Clinical Oncology	1999	245
Presentation, treatment, and outcome of local recurrence after skin-sparing mastectomy and immediate breast reconstruction Lisa A. Newman, Henry M. Kuerer, Kelly K. Hunt, Annals of Surgical Oncology MedicineReconstructive SurgeryBreast CancerSurgeryDermatology	1998	243

Page 1